Holen Sie sich die Stockscreener-App
6.58
1.64%
-0.11
Handel nachbörslich:
6.58
Schlusskurs vom Vortag:
$6.69
Offen:
$6.6
24-Stunden-Volumen:
59,982
Relative Volume:
0.65
Marktkapitalisierung:
$71.25M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00186
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
-2.23%
1M Leistung:
+37.66%
6M Leistung:
-18.16%
1J Leistung:
-42.98%
1-Tages-Spanne:
$6.58
$6.8882
1-Wochen-Bereich:
$6.3551
$6.9255
52-Wochen-Spanne:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
6.58 | 72.44M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
What are analysts’ price targets for Avalo Therapeutics Inc. in the next 12 monthsBest Dividend Tips With High Returns - jammulinksnews.com
What are the technical indicators suggesting about Avalo Therapeutics Inc.Invest confidently with real-time market updates - jammulinksnews.com
How to forecast Avalo Therapeutics Inc. trends using time seriesHigh Return Idea With Technical Filter - Newser
Real time pattern detection on Avalo Therapeutics Inc. stockFree Chart Alert System With Entry Targets - Newser
Is Avalo Therapeutics Inc. still worth holding after the dip Free Stable Entry High Return Opportunities - Newser
What is Avalo Therapeutics Inc. company’s growth strategyFree Consultation - jammulinksnews.com
What is the dividend policy of Avalo Therapeutics Inc. stockBuild a portfolio that delivers consistent profits - jammulinksnews.com
What institutions are buying Avalo Therapeutics Inc. stock nowStable Stocks With High Yield - Newser
Moving Average Trends for Avalo Therapeutics Inc. Stock: What They IndicateFree Access to Community with 300% Return - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchSteady Profit Stock Forecasts - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionWatchlist Winner Update - Newser
What analysts say about Avalo Therapeutics Inc. stockSky-high profits - PrintWeekIndia
What drives Avalo Therapeutics Inc. stock priceHigh-yield investments - PrintWeekIndia
Avalo Therapeutics Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia
When is the best time to buy Avalo Therapeutics Inc. stockExponentially increasing returns - jammulinksnews.com
Is Avalo Therapeutics Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com India
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target By Investing.com - Investing.com South Africa
Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest
Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest
What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser
How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):